Advancement and applications of nanotechnology in breast surgery:  a comprehensive literature review

Tahmina Hakim; Azra Tabassum; Caitlin Lim

doi:10.18203/2349-2902.isj20253734

Authors

Tahmina Hakim Department of General Surgery, Campbelltown Hospital, New South Wales, Australia
Azra Tabassum Department of General Surgery, St George Hospital, New South Wales, Australia
Caitlin Lim Department of General Surgery, Campbelltown Hospital, New South Wales, Australia

DOI:

https://doi.org/10.18203/2349-2902.isj20253734

Keywords:

Breast surgery, Nanotechnology, Targeted drug therapy, Diagnostic imaging, Post-operative wound healing

Abstract

Breast cancer is the most common malignancy affecting women worldwide and remains a major cause of cancer-related mortality. Although conventional treatments such as surgery, chemotherapy, and radiotherapy are effective in early stages, their efficacy decreases in advanced and metastatic cases. Nanotechnology has emerged as a transformative approach in oncology, offering precise diagnosis, targeted therapy, and innovative surgical applications. This review synthesizes recent literature on nanotechnology-based strategies in breast cancer management, emphasizing diagnostic imaging, targeted drug delivery, surgical enhancement, and postoperative wound healing. Databases including PubMed, Scopus, and Google Scholar were searched for relevant studies published between 2015 and 2024, focusing on preclinical and clinical advancements. Nanomaterials such as liposomes, micelles, dendrimers, and metallic nanoparticles have shown significant promise in improving therapeutic efficacy through site-specific delivery and controlled drug release. Intraoperative imaging agents and nanoprobes facilitate accurate tumour margin identification and sentinel lymph node (SLN) mapping. Nanofibers and nanohydrogels enhance wound repair and reduce infection risk. Emerging theranostic and nanorobotic systems integrate diagnostic and therapeutic functions, improving surgical precision while minimizing tissue damage and systemic toxicity. Nanotechnology is reshaping the landscape of breast cancer surgery and treatment. Its integration into diagnostic and therapeutic protocols enhances precision, minimizes invasiveness, and optimizes patient outcomes. Despite promising preclinical evidence, clinical translation remains limited by challenges such as biocompatibility, immune clearance, and regulatory barriers. Continued interdisciplinary research is essential to advance nanotechnology toward safe, effective, and personalized breast cancer care.

Metrics

Metrics Loading ...

References

Tagde P, Najda A, Nagpal K, Kulkarni GT, Shah M, Ullah O, et al. Nanomedicine-Based Delivery Strategies for Breast Cancer Treatment and Management. Int J Mol Sci. 2022;23(5):2856. DOI: https://doi.org/10.3390/ijms23052856

Hou K, Ning Z, Chen H, Wu Y. Nanomaterial Technology and Triple Negative Breast Cancer. Front Oncol. 2022;11:828810. DOI: https://doi.org/10.3389/fonc.2021.828810

Lin X, Wang Y, Fang K, Guo Z, Lin N, Li L. The application of nanoparticles in theranostic systems targeting breast cancer stem cells: current progress and future challenges. Stem Cell Res Ther. 2023;14(1):356. DOI: https://doi.org/10.1186/s13287-023-03584-1

Abaszadeh F, Ashoub MH, Khajouie G, Amiri M. Nanotechnology development in surgical applications: recent trends and developments. Eur J Med Res. 2023;28(1):537. DOI: https://doi.org/10.1186/s40001-023-01429-4

Bhat SA, Kumar V, Dhanjal DS, Gandhi Y, Mishra SK, Singh S, et al. Biogenic nanoparticles: pioneering a new era in breast cancer therapeutics-a comprehensive review. Discov Nano. 2024;19(1):121. DOI: https://doi.org/10.1186/s11671-024-04072-y

Kan-Dapaah K, Rahbar N, Soboyejo W. Polymeric composite devices for localized treatment of early-stage breast cancer. PLoS One. 2017;12(2):e0172542. DOI: https://doi.org/10.1371/journal.pone.0172542

Lan H, Jamil M, Ke G, Dong N. The role of nanoparticles and nanomaterials in cancer diagnosis and treatment: a comprehensive review. Am J Cancer Res. 2023;13(12):5751-84.

Ganesan K, Wang Y, Qingqing L, Chen Z, Peng L, et al. Targeting engineered nanoparticles for breast cancer therapy. Pharmaceutics. 2021;13(11):1829. DOI: https://doi.org/10.3390/pharmaceutics13111829

Liu H, Zhu X, Wei Y, Song C, Wang Y. Recent advances in targeted gene silencing and cancer therapy by nanoparticle-based delivery systems. Biomed Pharmacother. 2023;157:114065. DOI: https://doi.org/10.1016/j.biopha.2022.114065

Miao L, Kang Y, Zhang XF. Nanotechnology for the theranostic opportunity of breast cancer lung metastasis: recent advancements and future challenges. Front Bioeng Biotechnol. 2024;12:1410017. DOI: https://doi.org/10.3389/fbioe.2024.1410017

Lee J, Chatterjee DK, Lee MH, Krishnan S. Gold nanoparticles in breast cancer treatment: promise and potential pitfalls. Cancer Lett. 2014;347(1):46-53. DOI: https://doi.org/10.1016/j.canlet.2014.02.006

Sapienza Passos J, Dartora VFMC, Cassone Salata G, Draszesski Malagó I, Lopes LB. Contributions of nanotechnology to the intraductal drug delivery for local treatment and prevention of breast cancer. Int J Pharm. 2023;635:122681. DOI: https://doi.org/10.1016/j.ijpharm.2023.122681

Wu L, He C, Zhao T, Li T, Xu H, Wen J, et al. Diagnosis and treatment status of inoperable locally advanced breast cancer and the application value of inorganic nanomaterials. J Nanobiotechnology. 2024;22(1):366. DOI: https://doi.org/10.1186/s12951-024-02644-9

Guha L, Bhat IA, Bashir A, Rahman JU. Nanotechnological approaches for the treatment of triple-negative breast cancer: a comprehensive review. Curr Drug Metab. 2022;23(10):781-99. DOI: https://doi.org/10.2174/1389200223666220608144551

Ahmed M, Peek MC, Douek M. How can nanoparticles be used in sentinel node detection? Nanomedicine. 2017;12(13):1525-7. DOI: https://doi.org/10.2217/nnm-2017-0137

Radenkovic D, Kobayashi H, Remsey-Semmelweis E, Seifalian AM. Quantum dot nanoparticle for optimization of breast cancer diagnostics and therapy in a clinical setting. Nanomedicine. 2016;12(6):1581-92. DOI: https://doi.org/10.1016/j.nano.2016.02.014

Ahmed M, Douek M. The role of magnetic nanoparticles in the localization and treatment of breast cancer. Biomed Res Int. 2013;2013:281230. DOI: https://doi.org/10.1155/2013/281230

Li J, Zhuang Z, Jiang B, Zhao P, Lin C. Advances and perspectives in nanoprobes for noninvasive lymph node mapping. Nanomedicine. 2015;10(6):1019-36. DOI: https://doi.org/10.2217/nnm.14.201

Meng X, Wang X, Zhang Z, Song L, Chen J. Recent Advancements of Nanomedicine in Breast Cancer Surgery. Int J Nanomedicine. 2024;19:14143-69. DOI: https://doi.org/10.2147/IJN.S494364

Sevieri M, Sitia L, Bonizzi A, Truffi M, Mazzucchelli S, Corsi F. Tumor accumulation and off-target biodistribution of an indocyanine-green fluorescent nanotracer: an ex vivo study on an orthotopic murine model of breast cancer. Int J Mol Sci. 2021;22:1601. DOI: https://doi.org/10.3390/ijms22041601

Kong X, Gao P, Wang J, Fang Y, Hwang KC. Advances of medical nanorobots for future cancer treatments. J Hematol Oncol. 2023;16(1):74. DOI: https://doi.org/10.1186/s13045-023-01463-z

Neagu AN, Jayaweera T, Weraduwage K, Darie CC. A Nanorobotics-Based Approach of Breast Cancer in the Nanotechnology Era. Int J Mol Sci. 2024;25(9):4981. DOI: https://doi.org/10.3390/ijms25094981